Innovent CFO Sees a Lot of Opportunities in China's Health Market

The transcript discusses the challenges and opportunities in the Chinese healthcare sector, focusing on regulatory changes, market needs, and product development. It highlights the company's strategy to leverage these opportunities through innovation and a strong product pipeline, including anti-cancer and arthritis drugs. The discussion also covers investment needs, profitability timelines, and maintaining quality standards to build reputation and compete globally. Despite US-China trade tensions, the company remains focused on its mission to provide advanced biological products.

What types of products is the company focusing on for development?

How does the company ensure the quality of its products?

What impact do US-China trade tensions have on the company's operations?